Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "health"

4314 News Found

Cipla to acquire Inzpera Healthsciences for Rs. 110.65 Cr
News | November 04, 2025

Cipla to acquire Inzpera Healthsciences for Rs. 110.65 Cr

The transaction is expected to be completed within one month from the signing of the definitive agreements.


Dr Agarwals Health Care posts consolidated Q2 FY26 PAT at Rs. 29.69 Cr
News | November 02, 2025

Dr Agarwals Health Care posts consolidated Q2 FY26 PAT at Rs. 29.69 Cr

Dr Agarwals Health Care has reported total income of Rs. 506.62 crore during the period ended September 30, 2025


MedPlus Health Services posts consolidated Q2 FY26 PAT at Rs. 55.50 Cr
News | November 02, 2025

MedPlus Health Services posts consolidated Q2 FY26 PAT at Rs. 55.50 Cr

Medplus Health Services has reported total income of Rs. 1,696.79 crore during the period ended September 30, 2025


India’s healthcare and pharma sectors recorded a total of 72 transactions valued at US$ 3.5 billion in Q3 2025: Grant Thornton Bharat
News | October 31, 2025

India’s healthcare and pharma sectors recorded a total of 72 transactions valued at US$ 3.5 billion in Q3 2025: Grant Thornton Bharat

The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million


Lupin Digital Health launches VITALYFE
Healthcare | October 31, 2025

Lupin Digital Health launches VITALYFE

AI-powered cardiometabolic wellness platform for India’s workforce


Zydus receives approval from Health Canada for Mesalamine suppositories
News | October 27, 2025

Zydus receives approval from Health Canada for Mesalamine suppositories

Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis


Health Minister Nadda addresses 50th convocation of AIIMS New Delhi
News | October 27, 2025

Health Minister Nadda addresses 50th convocation of AIIMS New Delhi

In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels


Biocon Biologics secures Health Canada nod for biosimilars Yesintek, Yesintek IV
News | October 23, 2025

Biocon Biologics secures Health Canada nod for biosimilars Yesintek, Yesintek IV

Yesintek and Yesintek I.V. are approved for the treatment of moderate to severe plaque psoriasis in adults and pediatric patients


Bajaj Healthcare posts Q2 FY26 PAT at Rs. 11.10 Cr
News | October 22, 2025

Bajaj Healthcare posts Q2 FY26 PAT at Rs. 11.10 Cr

Bajaj Healthcare has reported total income of Rs. 149.56 crore during the period ended September 30, 2025